U.S. flag

An official website of the United States government

NM_206937.2(LIG4):c.833G>T (p.Arg278Leu) AND DNA ligase IV deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003509002.2

Allele description [Variation Report for NM_206937.2(LIG4):c.833G>T (p.Arg278Leu)]

NM_206937.2(LIG4):c.833G>T (p.Arg278Leu)

Gene:
LIG4:DNA ligase 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q33.3
Genomic location:
Preferred name:
NM_206937.2(LIG4):c.833G>T (p.Arg278Leu)
HGVS:
  • NC_000013.11:g.108210436C>A
  • NG_007396.1:g.10099G>T
  • NM_001098268.2:c.833G>T
  • NM_001330595.2:c.632G>T
  • NM_001352598.2:c.833G>T
  • NM_001352599.2:c.833G>T
  • NM_001352600.2:c.833G>T
  • NM_001352601.2:c.833G>T
  • NM_001352602.2:c.833G>T
  • NM_001352603.1:c.833G>T
  • NM_001352604.2:c.869G>T
  • NM_001379095.1:c.833G>T
  • NM_002312.3:c.833G>T
  • NM_206937.2:c.833G>TMANE SELECT
  • NP_001091738.1:p.Arg278Leu
  • NP_001317524.1:p.Arg211Leu
  • NP_001339527.1:p.Arg278Leu
  • NP_001339528.1:p.Arg278Leu
  • NP_001339529.1:p.Arg278Leu
  • NP_001339530.1:p.Arg278Leu
  • NP_001339531.1:p.Arg278Leu
  • NP_001339532.1:p.Arg278Leu
  • NP_001339533.1:p.Arg290Leu
  • NP_001366024.1:p.Arg278Leu
  • NP_002303.2:p.Arg278Leu
  • NP_996820.1:p.Arg278Leu
  • LRG_79t1:c.833G>T
  • LRG_79:g.10099G>T
  • LRG_79p1:p.Arg278Leu
  • NC_000013.10:g.108862784C>A
Protein change:
R211L
Molecular consequence:
  • NM_001098268.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330595.2:c.632G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352598.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352599.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352600.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352601.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352602.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352603.1:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352604.2:c.869G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379095.1:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002312.3:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_206937.2:c.833G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
DNA ligase IV deficiency
Synonyms:
Lig4 syndrome
Identifiers:
MONDO: MONDO:0011686; MedGen: C1847827; Orphanet: 99812; OMIM: 606593

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004296524Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 14, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular and immunological characterization of DNA ligase IV deficiency.

Jiang J, Tang W, An Y, Tang M, Wu J, Qin T, Zhao X.

Clin Immunol. 2016 Feb;163:75-83. doi: 10.1016/j.clim.2015.12.016. Epub 2016 Jan 4.

PubMed [citation]
PMID:
26762768

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004296524.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LIG4 protein function. This missense change has been observed in individual(s) with LIG4 syndrome (PMID: 26762768). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.06%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 278 of the LIG4 protein (p.Arg278Leu).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 1, 2025